Essence Pharmaceutical (002349.SZ): Lopinavir approved for listing of chemical raw materials

date
24/07/2025
Zhixin Finance APP news, Essence Pharmaceuticals (002349.SZ) issued an announcement. Recently, the company's subsidiary, Essence Pharmaceuticals Group Nantong Co., Ltd. (referred to as "Nantong Company" below), has obtained the approval and issuance of the "Notice of Approval for the Market Application of Lopinavir Chemical Raw Materials" by the National Medical Products Administration.